Spots Global Cancer Trial Database for Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer
Official Title: A Randomised, Non-Comparative, Multicentre, Phase II, Parallel-Group Trial Of ZD1839 (Iressa™) In Combination With 5 Fluorouracil, Leucovorin And Cpt-11 (Irinotecan) In Patients With Metastatic Colorectal Cancer
Study ID: NCT00233623
Conditions
Study Description
Brief Summary: The aim of the study is to determine if Iressa added to chemotherapy with Irinotecan, 5Fluorouracil and Leucovorin can prolong the period of time without any disease worsening (Time to Progression) in patients with metastatic colorectal cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Center, Bari, , Italy
Research Site, Bergamo, , Italy
Research Site, Catania, , Italy
Research Site, Cremona, , Italy
Research Site, Cuneo, , Italy
Research Site, L'Aquila, , Italy
Research Site, La Spezia, , Italy
Research Site, Milano, , Italy
Research Site, Palermo, , Italy
Research Site, Pescara, , Italy
Research Site, Rozzano, , Italy
Research Site, Torino, , Italy
Research Site, Venezia, , Italy
Contact Details
Name: AstraZeneca Italy Medical Director, MD
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
